- Home
- GEVO vs ETHZ Comparison
GEVO vs ETHZ Comparison
Compare GEVO & ETHZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- ETHZ
- Stock Information
- Founded
- GEVO 2005
- ETHZ N/A
- Country
- GEVO United States
- ETHZ United States
- Employees
- GEVO N/A
- ETHZ N/A
- Industry
- GEVO Major Chemicals
- ETHZ Biotechnology: Pharmaceutical Preparations
- Sector
- GEVO Industrials
- ETHZ Health Care
- Exchange
- GEVO Nasdaq
- ETHZ Nasdaq
- Market Cap
- GEVO 418.4M
- ETHZ 465.0M
- IPO Year
- GEVO 2011
- ETHZ N/A
- Fundamental
- Price
- GEVO $1.67
- ETHZ $2.31
- Analyst Decision
- GEVO Buy
- ETHZ
- Analyst Count
- GEVO 2
- ETHZ 0
- Target Price
- GEVO $7.58
- ETHZ N/A
- AVG Volume (30 Days)
- GEVO 9.5M
- ETHZ 30.2M
- Earning Date
- GEVO 11-06-2025
- ETHZ 10-26-2025
- Dividend Yield
- GEVO N/A
- ETHZ N/A
- EPS Growth
- GEVO N/A
- ETHZ N/A
- EPS
- GEVO N/A
- ETHZ N/A
- Revenue
- GEVO $80,187,000.00
- ETHZ N/A
- Revenue This Year
- GEVO $909.99
- ETHZ N/A
- Revenue Next Year
- GEVO $22.37
- ETHZ N/A
- P/E Ratio
- GEVO N/A
- ETHZ N/A
- Revenue Growth
- GEVO 341.75
- ETHZ N/A
- 52 Week Low
- GEVO $0.67
- ETHZ $0.66
- 52 Week High
- GEVO $3.39
- ETHZ $17.75
- Technical
- Relative Strength Index (RSI)
- GEVO 53.71
- ETHZ N/A
- Support Level
- GEVO $1.54
- ETHZ N/A
- Resistance Level
- GEVO $1.80
- ETHZ N/A
- Average True Range (ATR)
- GEVO 0.10
- ETHZ 0.00
- MACD
- GEVO -0.02
- ETHZ 0.00
- Stochastic Oscillator
- GEVO 40.62
- ETHZ 0.00
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.